tiprankstipranks
Trending News
More News >
Northwest Biotherapeutics (NWBO)
OTHER OTC:NWBO

Northwest Biotherapeutics (NWBO) Revenue

Compare
485 Followers

Northwest Biotherapeutics Revenue

Northwest Biotherapeutics had a revenue of 357.00K in the quarter ending Sep 30, 2024, with -30.00%. This bring the company's revenue in the last twelve months to 1.60M, Increased -2.98%. In the fiscal year ending Dec 31, 2023, Northwest Biotherapeutics had annual revenue of 1.93M with 14.80% growth.
Revenue (ttm)
1.60M
Revenue Growth
P/S Ratio
229.56
Revenue/Employee
$77,280
Employees
25
Market Cap
$443.51M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 20231.93M249.00K+14.80%
Dec 31, 20221.68M678.00K+67.46%
Dec 31, 20211.00M-286.00K-22.15%
Dec 31, 20201.29M-1.12M-46.43%
Dec 31, 20192.41M2.00M+484.95%
Dec 31, 2018412.00K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis